Natixis Advisors’s Nu Skin NUS Stock Holding History

Natixis Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,888	Closed	-$234K	–	1615
2024 Q1	$234K	Buy	+16,888	New	+$264K	﹤0.01%	1504

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's NUS Position: Q2 2024 in Review

Natixis Advisors sold out of Nu Skin (NUS) in Q2 2024, closing a stake of 16,888 shares — an estimated $234K sold.

Natixis Advisors first reported a position in NUS in Q1 2024 and held it in 1 quarter. The position peaked at $234K in Q1 2024. 202 funds tracked by Wall St. Rank hold NUS as of Q2 2024.

Natixis Advisors reported no remaining Nu Skin position as of Q2 2024 after selling out during the quarter.
Natixis Advisors sold 16,888 Nu Skin shares in Q2 2024, an estimated $234K.
Natixis Advisors first reported a position in Nu Skin in Q1 2024 and held it in 1 quarter.
Natixis Advisors's Nu Skin position peaked at $234K in Q1 2024.
202 funds tracked by Wall St. Rank held Nu Skin as of Q2 2024.

Based on Natixis Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.